Saltar al contenido principal

ETHNOS_APP

Inicio • Búsqueda • Revistas • Lista 0

Jeffrey W Cannon

Datos Biográficos

ID9799631
NOMBREJeffrey W Cannon
NOMBRESJeffrey W
APELLIDOCannon
FIRMACANNON J W
AFILIACIONESThe Kids Research Institute Australia
VERIFICADONo
TOTAL DE OBRAS3
TOTAL DE CITAS0
TOTAL COMO AUTOR3
TOTAL COMO EDITOR0
PRIMER AÑO DE PUBLICACIÓN2023
AÑO MÁS RECIENTE DE PUBLICACIÓN2023
ÍNDICE H0
  • Tertiary prevention and treatment of rheumatic heart disease

    Open Access•Dominique Vervoort, Christopher Sabo Yilgwan et al.•ARTICLE•BMJ Global Health•2023

    Although entirely preventable, rheumatic heart disease (RHD), a disease of poverty and social disadvantage resulting in high morbidity and mortality, remains an ever-present burden in low-income and middle-income countries (LMICs) and rural, remote, marginalised and disenfranchised populations within high-income countries. In late 2021, the National Heart, Lung, and Blood Institute convened a workshop to explore the current state of science, to i…

  • Research opportunities for the primordial prevention of rheumatic fever and rheumatic heart disease—streptococcal vaccine development

    Open Access•Alma Fulurija, Madeleine W Cunningham et al.•ARTICLE•BMJ Global Health•2023

    Streptococcus pyogenes, also known as group A streptococcus (StrepA), is a bacterium that causes a range of human diseases, including pharyngitis, impetigo, invasive infections, and post-infection immune sequelae such as rheumatic fever and rheumatic heart disease. StrepA infections cause some of the highest burden of disease and death in mostly young populations in low-resource settings. Despite decades of effort, there is still no licensed Stre…

  • Research opportunities for the primary prevention and management of acute rheumatic fever and rheumatic heart disease

    Open Access•Joselyn Rwebembera, Jeffrey Cannon et al.•ARTICLE•BMJ Global Health•2023

    Primary prevention of acute rheumatic fever (ARF) and rheumatic heart disease (RHD) encompasses the timely diagnosis and adequate treatment of the superficial group A Streptococcus (GAS) infections pharyngitis and impetigo. GAS is the only known inciting agent in the pathophysiology of the disease. However, sufficient evidence indicates that the uptake and delivery of primary prevention approaches in RHD-endemic regions are significantly suboptim…

Sin obras prominentes en esta página.

  • Tertiary prevention and treatment of rheumatic heart disease

    Open Access•Dominique Vervoort, Christopher Sabo Yilgwan et al.•ARTICLE•BMJ Global Health•2023

    Although entirely preventable, rheumatic heart disease (RHD), a disease of poverty and social disadvantage resulting in high morbidity and mortality, remains an ever-present burden in low-income and middle-income countries (LMICs) and rural, remote, marginalised and disenfranchised populations within high-income countries. In late 2021, the National Heart, Lung, and Blood Institute convened a workshop to explore the current state of science, to i…

  • Research opportunities for the primordial prevention of rheumatic fever and rheumatic heart disease—streptococcal vaccine development

    Open Access•Alma Fulurija, Madeleine W Cunningham et al.•ARTICLE•BMJ Global Health•2023

    Streptococcus pyogenes, also known as group A streptococcus (StrepA), is a bacterium that causes a range of human diseases, including pharyngitis, impetigo, invasive infections, and post-infection immune sequelae such as rheumatic fever and rheumatic heart disease. StrepA infections cause some of the highest burden of disease and death in mostly young populations in low-resource settings. Despite decades of effort, there is still no licensed Stre…

  • Research opportunities for the primary prevention and management of acute rheumatic fever and rheumatic heart disease

    Open Access•Joselyn Rwebembera, Jeffrey Cannon et al.•ARTICLE•BMJ Global Health•2023

    Primary prevention of acute rheumatic fever (ARF) and rheumatic heart disease (RHD) encompasses the timely diagnosis and adequate treatment of the superficial group A Streptococcus (GAS) infections pharyngitis and impetigo. GAS is the only known inciting agent in the pathophysiology of the disease. However, sufficient evidence indicates that the uptake and delivery of primary prevention approaches in RHD-endemic regions are significantly suboptim…

Medicine (3 obras) · Streptococcal Infections and Treatments (3 obras) · Antimicrobial Resistance in Staphylococcus (2 obras) · Disease (2 obras) · Heart disease (2 obras) · Immunology (2 obras) · Infective Endocarditis Diagnosis and Management (2 obras) · Intensive care medicine (2 obras) · Pathology (2 obras) · Pharyngitis (2 obras)

Ethnos_APP • Proyecto Open Source • Licencia MIT • Frontend v2.0.0 • Privacidad y Cookies • Documentación de la API: api.ethnos.app/docs • Código de la API: GitHub • DOI: 10.5281/zenodo.17049435 • Código del Frontend: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae